Telisotuzumab Antibody
Telisotuzumab (ABT-700) is a humanized anti-c-MET monoclonal antibody that potently inhibits MET signaling pathways. It has demonstrated antitumor activity in preclinical models, supporting its investigation in oncology research, particularly for MET-dysregulated cancers, in both in vitro and in vivo experimental settings.
Product Specifications
Product Name Alternative
Mab-224G11, HGFR, ABT 700, ABT700, ABT-700, c-Met, cMet, cMet/HGFR, Telisotuzumab
Target
C-Met/HGFR, Apoptosis
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Signal Transduction
Concentration
4.71 mg/mL
Purity
96.10% (May vary between batches)
Molecular Weight
145.50 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![tert-Butyl 3-Bromo-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate](https://cdn.genprice.uk/products/572/5594354889976/imageurl/trc-b789334-25mg.webp)
TRC-B789334-25MG 25 mg
tert-Butyl 3-Bromo-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate
Sign In for Pricing
View Details 